In 2025, the global digital medical field is undergoing an unprecedented change. Faced with this historic opportunity, Huawei, a technology giant known for its technological innovation, is deeply involved and leading this change with its unique strategic vision and all-round layout.
Huawei’s strategic layout in the health industry has long surpassed the role of traditional technology suppliers. From the establishment of the highly strategic medical and health corps, to the continuous iterative and innovative smart wearable devices, to the implementation and application of artificial intelligence models in multiple medical scenarios, Huawei is building a full ecological system covering “end-edge-cloud-digital-intelligence”, striving to empower smart medical care in all aspects.
In March 2025, the establishment of Huawei’s Medical and Health Corps undoubtedly marks Huawei’s official upgrade of the health industry to a strategic core track. This innovative organizational structure directly focuses on the key pain points of the medical industry and relies on its strong “cloud-edge-end” collaboration capabilities to build a solid digital foundation for smart medical care. Huawei’s technology integration capabilities are particularly worthy of attention. For example, relying on Asteng computing architecture and Pangu big model, it provides the medical industry with comprehensive support from underlying data storage to upper-level algorithm optimization. Huawei’s in-depth cooperation with industry-leading companies such as WuXi AppTec and BGI have not only significantly shortened the new drug research and development cycle, but also greatly improved the processing and analysis efficiency of genomic data and accelerated the implementation of precision medicine.
In the field of consumer-grade health management, Huawei’s smart wearable devices also show their strength to lead the industry trend. Huawei Band 10 and WATCH D2 series provide users with more comprehensive and personalized health management solutions with their innovative functions in sleep HRV monitoring, emotional health assistant, AI swimming posture recognition, etc. It is particularly worth mentioning that WATCH D2, as the world’s first smart watch that supports dynamic blood pressure monitoring, is equipped with a Xuanji perception system that can achieve 24-hour full-scene blood pressure monitoring and has obtained medical device certification from many countries and regions including China and the EU. This innovative breakthrough not only brings users a more convenient and accurate health monitoring experience, but also actively promotes the standardization process of wearable devices in the field of clinical applications. It is worth noting that the accuracy of dynamic blood pressure monitoring and the effectiveness of long-term use are still areas that require continuous attention and further research.
In terms of global layout, Huawei’s health industry strategy presents the dual characteristics of “technology output + localization adaptation”. On the one hand, Huawei actively participates in medical infrastructure projects in countries along the “Belt and Road”, and has carried out in-depth cooperation with Saudi Arabia and other countries in areas such as artificial intelligence diagnosis and treatment, digital medical talent training, and is committed to improving the level and efficiency of local medical services. On the other hand, Huawei is also actively cooperating with medical institutions in Europe, Southeast Asia and other places to export customized smart healthy city solutions. In order to better meet the differentiated needs of overseas markets, Huawei has also launched the “Food Diary” function covering diet data in 50 countries and regions, fully taking into account the food culture characteristics of different regions.
In terms of business model innovation, Huawei is also constantly exploring sustainable profit models for the health industry. Through various methods such as building a B2B2C ecosystem, promoting subscription services, and pursuing an open platform strategy, Huawei is working hard to build a closed-loop healthy ecosystem of “data-model-service”. For example, the “Interactive Insurance” launched in cooperation with China Merchants Renhe Life Insurance realizes dynamic adjustment of premiums through the health data collected by users’ wearable devices, which not only reduces customer acquisition costs, but also creates an innovative model of “data-insurance-health services”. In addition, Huawei is actively exploring enterprise health management solutions to provide enterprise customers with employee health data insights and customized intervention plans, thereby further expanding the market space of the health industry. The effectiveness of corporate health management depends largely on employee participation and the scientificity and personalization of intervention plans.
Overall, Huawei’s strategic layout and practice in the health industry not only fully demonstrates its strong strength in technological innovation, but also reflects its deep understanding and active reconstruction of the paradigm of medical resource allocation and health management. With the continuous deepening of global digital medical transformation, Huawei’s health industry strategy will undoubtedly have a long-term and far-reaching impact on the future pattern of the global health industry. However, while developing rapidly, issues such as data security, privacy protection, and ethics also need to be fully paid attention and properly resolved.
